Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylene blue MMX for intraepithelial neoplasia detection in long-standing ulcerative colitis
2011-005693-36Phase 2Completed
- Sponsor
- Cosmo Pharmaceuticals
- Start
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of methylene blue in autoimmune colitis, Colorectal Dysplasia, sponsored by Cosmo Pharmaceuticals. Started Mar 2012; status: completed.
02
Drugs
methylene blue
03
Conditions
autoimmune colitisColorectal Dysplasia
Beyond the preview
Go deeper on 2011-005693-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005693-36.